Accessibility Menu
 
Pharma-Bio Serv logo

Pharma-Bio Serv

(OTC) PBSV

Current Price$0.50
Market Cap$11.45M
Since IPO (2006)-11%
5 Year-31%
1 Year+25%
1 Month+0%

Pharma-Bio Serv Financials at a Glance

Market Cap

$11.45M

Revenue (TTM)

$1.97B

Net Income (TTM)

$76.14K

EPS (TTM)

$-0.00

P/E Ratio

-151.52

Dividend

$0.00

Beta (Volatility)

0.17 (Low)

Price

$0.50

Volume

2,250

Open

$0.47

Previous Close

$0.50

Daily Range

$0.47 - $0.50

52-Week Range

$0.35 - $1.19

PBSV News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Pharma-Bio Serv

Industry

Life Sciences Tools and Services

Employees

75

CEO

Victor Sanchez, MBA

Headquarters

Dorado, PR 00646, US

PBSV Financials

Key Financial Metrics (TTM)

Gross Margin

29%

Operating Margin

-16%

Net Income Margin

-0%

Return on Equity

-68%

Return on Capital

-3%

Return on Assets

-0%

Earnings Yield

-0.66%

Dividend Yield

0.00%

Payout Ratio

-22581.69%

Stock Overview

Market Cap

$11.45M

Shares Outstanding

22.90M

Volume

2.25K

Avg. Volume

1.54K

Financials (TTM)

Gross Profit

$2.91M

Operating Income

$637.66K

EBITDA

$134.81K

Operating Cash Flow

$214.89K

Capital Expenditure

$6.64K

Free Cash Flow

$221.53K

Cash & ST Invst.

$10.85M

Total Debt

$28.83K

Pharma-Bio Serv Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q1 2026YOY CHG

Revenue

$2.29M

-7.1%

Gross Profit

$722.37K

-6.0%

Gross Margin

31.48%

N/A

Market Cap

$11.45M

N/A

Market Cap/Employee

$152.68K

N/A

Employees

75

N/A

Net Income

$32.86K

+285.0%

EBITDA

$50.35K

-21.7%

Quarterly Fundamentals

Name
Q1 2026YOY CHG

Net Cash

$10.56B

+85890.4%

Accounts Receivable

$2.65M

-1.0%

Inventory

$0.00

N/A

Long Term Debt

$0.00

N/A

Short Term Debt

$0.00

-100.0%

Return on Assets

-0.00%

N/A

Return on Invested Capital

-3.07%

N/A

Free Cash Flow

$390.14M

-90738.6%

Operating Cash Flow

$390.14M

-90738.6%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
NUMIFNuminus Wellness Inc.
$0.03+24.38%
SPLTFSpotLite360 IOT Solutions, Inc.
$0.08+0.00%
VYNDVynleads, Inc.
$0.43+0.00%
UDOCFUnidoc Health Corp.
$0.08+18.31%

Trending Stocks

Symbol / CompanyPricePrice Chg
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$13.07+0.05%
NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF
$5.70+0.01%
SOFISoFi Technologies
$16.43+0.02%
TQQQProShares Trust - ProShares UltraPro Qqq
$65.30+0.03%

Questions About PBSV

What is the current price of Pharma-Bio Serv?

Pharma-Bio Serv is trading at $0.50 per share.

What is the 52-week range for Pharma-Bio Serv?

Over the past 52 weeks, Pharma-Bio Serv has traded between $0.35 and $1.19.

How much debt does Pharma-Bio Serv have?

As of the most recent reporting period, Pharma-Bio Serv reported total debt of N/A.

How much cash does Pharma-Bio Serv have on hand?

Pharma-Bio Serv reported $5.76M in cash and cash equivalents in its most recent financial results.

What is Pharma-Bio Serv’s dividend yield?

Pharma-Bio Serv does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.